Drinking After a Diagnosis A study illuminates the alcohol consumption habits of cancer survivors. by Jen Tota McGivney Nothing but Time A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he’ll be remembered. by Adam P. Stern Opioid Overdoses in Cancer Patients and Survivors The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group. by Emma Yasinski Preparing Patients for Radiation Therapy Side Effects A study shows that some cancer patients wish they had known more about possible adverse effects of treatment. by Jon Kelvey When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro New Drugs for an Elusive Cancer Target Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein. by Anna Azvolinsky Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Food Insecurity and Cancer After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank. by Jen Tota McGivney “Congrats! You Have the ‘Good’ Cancer” Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer. by Carly Flumer Progress, But Still Room for Improvement The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients. by Kevin McLaughlin next